emeritus
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Oregon enforcement might be reducing cannabis inventories faster than we. Oils have dreamed of:
Portland, Ore. -- The Oregon Liquor Control Commission today announced results of recent enforcement inspections of recreational marijuana producers indicating most of the inspected licensees are in compliance with Oregon laws and OLCC rules. “Operation Good Harvest” was a saturation compliance effort focusing on Oregon’s fall 2018 legal outdoor cannabis harvest.
During “Operation Good Harvest” OLCC inspection teams were in the field from September to early November 2018 and conducted 354 inspections across the state, with particular focus on southern Oregon. The OLCC found that 259, or 73 percent of outdoor producer licensees did not have any “deficiencies” or potential violations.
Of the 95 licensees with discrepancies, 41 of the licensees have potential violations that could lead to the cancellations of their licensees. That represents about 12 percent of the outdoor producer licensees inspected.
“The results of Operation Good Harvest are promising, but just as when we started minor decoy activity focusing on licensed retailers, producer licensees not in compliance need to improve to stay licensed and operational,” said Steve Marks, OLCC Executive Director. “The inspections reflect our agency’s effort to prevent diversion from Oregon’s legal cannabis market, and we’ll continue compliance activity across all license categories to maintain the well-regulated market that Oregonians
Many of the licensees not in compliance had multiple deficiencies. Some of the most common were for problems with cameras and surveillance coverage – cameras didn’t work, didn’t provide proper coverage of the licensed premise or surveillance footage wasn’t recorded.
Other common violations included: data in the Cannabis Tracking System (METRC) not matching plants or product discovered on the licensed premises, marijuana plants not tagged and entered into METRC, and failure to provide the OLCC with harvest notification information – including unrecorded harvests.
Licensees were also found to be in violation for making unapproved alterations to their licensed premises, security and alarm issues and using scales not approved by the Oregon Department of Agriculture.
In September 2018 the OLCC put in place a rule requiring outdoor producers to provide the agency advance notice of harvest activity. The notification information along with CTS data was used to coordinate inspections.
The OLCC has 628 active outdoor and mixed use recreational marijuana producers, and during “Operation Good Harvest” the OLCC inspected 56 percent of legal outdoor and mixed use growers. Mixed use producers grow cannabis outdoors and indoors.
After OLCC recreational marijuana inspectors complete their investigations of licensees for alleged violations, the OLCC’s Administrative Policy and Process division will consider what charges to file against the licensees, including possible license cancellation.
Licensees are entitled to challenge OLCC charges through the State of Oregon’s Administrative Hearings process, but the final decision on any charges will be taken by the OLCC Commission.
Colorado, they test for less than 10 pesticides - we’re going to exceed (testing for) 60 pesticides.
Video: https://www.wptv.com/news/region-c-palm-beach-county/west-palm-beach/no-clear-guidelines-on-testing-for-medical-marijuana-in-florida
Massachusetts retail marijuana shops get 'signal to open' Tuesday from state Cannabis Control Commission.
https://www.masslive.com/news/index.ssf/2018/11/massachusetts_retail_marijuana.html
Ummmmmm no it isn’t? This is a business supposed to be working for shareholders and return not whether someone tried their best. Yay! Participation ribbons don’t pay my mortgage brah!
How so? Likes? Shares? Posts?
Nope. EVIO had no relationship with WW personal 800k financial matter. Other than the fact he’s the CEO and had a personal financial matter that some one on this board found and posted here. My best recollection was at the time the spin/speculation of the poster of the data was of a “stealth” acquisition of land in anticipation of a totally speculated Nevada Lab possibility. That narrative flamed out in a week or so and now, it’s pretty obvious that frustration with recent ongoing Corp comms / clarity / consistency etc that we are all (most anyways) wondering about leads some folks to make up something for entertainment or malice. All but Ghosting the shareholders will do that.
Florida EVIO ownership appears well funded and well managed. Haven’t found anything untoward. In fact I would suggest that EVIO corporate integrate more of the media/ communications model that Florida EVIO really does well.
The easy “15 second elevator pitch” nature of their comms that covers things broadly/ succinctly and pleasantly. Anything they put out has that very smooth ease of access to AnY investor who might stumble upon $EVIO for the first time/ and they always include graphics too! (VIP to reprint/uptake of 3rd parties - it’s pretty simple, right - if you’re an aggregator do you want content with cool graphics or not? Pretty simple which on gets chosen head to head). Contrast that with corporate comms that seem to believe they are only speaking to “insiders” or their “tribe” -
A pubco is an all inclusive endeavor that should be instantly accessible to ANY investor looking for a return and not just communicating in code to “true believers”
Equipped with cannabis testing equipment from SSI, EVIO Labs Florida can analyze more than 1,400 samples a day. SSI instruments include integrated high-performance liquid chromatographs (HPLC), designed specifically for quantitative determination of cannabinoid content. SSI also provided triple quadrupole Liquid Chromatograph Mass Spectrometers (LC-MS/MS), key instruments in the analysis of pesticides and mycotoxins.
In addition, SSI supplied Inductively Coupled Plasma Mass Spectrometers (ICP-MS) for sensitive trace element analysis to screen for heavy metals. Additional SSI instruments include a Gas Chromatograph (GC), triple quadrupole Gas Chromatograph Mass Spectrometers (GC-MS/MS), a Fourier-transform infrared (FTIR) spectrophotometer, a moisture balance and laboratory consumables such as columns solvents, standards and reagents.
https://www.cannabisbusinesstimes.com/article/shimadzu-scientific-instruments-evio-labs-florida/
Volume spike, no news. What gives?
The $80-100 million California target might be a lagging. My understanding was the heavy metals being included on Jan 1, 2019 as well as other expansions within existing suites had pushed the California testing market forecast upwards of 200 million dollars a year in testing revs in California. Regardless. You are correct. My projections are definitely on the optimistic side. I’d love to see a 10 released on Feb 15, 2021 with $80,000,000 in $evio fiscal 2020 revs. Might need a new team in to realize that goal. But I’m with you. Ash flowing positive numbers flowing out of California and Canada that should deliver numbers that see us trading well over 1$ trending to 2$ a share. They still haven’t clarified anything about the Canada listing w/drawl which is still? On? And there’s the German language promo pieces we’ve seen that hint at a Frankfurt listing being in play. The fundamentals remain but if they manage to get into both Canada and German stock exchanges in the next day 180 days - it will dovetail nicely with these strong revenues cash flowing in 2019 which might finally get us some long awaited irrational exuberance about the future
But a real IR team running a real normal program in all 3 countries would be critical to success. If they still haven’t figured it out yet. Hype and irrational exuberance and cash flow too. But the first two are critical to stemming the slow bleed of dilution. Get some son.
The only thing on Trumps mind regarding DOJ is mueller and possible indictments - whomever he taps to replace sessions will be recruited for that purview almost exclusively. Maybe the industry catches a break and that person is either supportive of or benign at least about the industry and not openly hostile like our Confederate Keebler Elf
imho political science stuff - i would suggest that Trump get his hatchet man to deal w mueller but to make sure he’s ok w cannabis. Because after yesterday’s romp of blue, and he’s bravely putting a positive spin on the results. But behind closed doors..... there’s an election in 2 years and from the looks of it you’re going to need to expand your narrative to win. Having an aggressive asshole mixing it up w the states - pissing business owners off. Consumers. Others. Who needs the aggravation in a close election. Put a guy in who won’t be wearing a hemp suit but at least someone who would say .... say the DOJ priority is not cannabis. Deal w cole memo. Do a big promo busts of fenatyl factories and meth seizures. Do a white powder task force and round up all the illegal gangsters. But leave taxpayers alone.
Michigan is in play as big vote state. Ffs UTAH legalized medical cannabis. UTAH! Like 85% of the state senate are active members of the LDS. UTAH!
It’s definitely $300 per test. Not split. One pesticide test. tME provided some intel on a rumored $400-600 for the pesticide test in Canada. Add onto that the THC/ Microbiological/ heavy metals/ optional terpene tests. And a “sample” as described in the goal target of 20 early 2019 and 40 late 2019 should be generating upwards of $1000 plus per “sample”
that represents a potential $5,200,000 - $10,400,000 in Canada testing revs 2019
I’d go out on a bit of a limb and say California has the exact same potential for 2019.
I had a number of $30,000,000 each from California and Canada as revenue targets. $50-60 million in testing revs in 2020. Throw in another $20,000,0000 from Oregon, MASS, Colorado, Florida Michigan? Nevada? Illinois? 70- 80,000,000 2020 $EVIO rev target.
This is the kind of projection I’d love to see from the company. Enough with the 3rd party data referencing.
The best recollection of Oregon costing for pesticide testing was around 300$ per - it’s the biggest revenue driver of the tests as it uses the most expensive equipment. Canada’s recent announcement of compulsory third party testing had like 90 different pesticides to be tested for vs a lot less than that in Oregon. So I think it’s safe to start at 300$ as the revenue generated from a test. And go up from there. But I’m with you overall. Evio needs to start putting out press releases with forecasts and details that shareholders can deep dive in. This constant referencing in every PR “arc view cannabis consultants say the market will be this big/ according to green ventures etc - every PR seems to do it. Three years in and evio management must have a better sense of their own marketplace and need to cease dropping these outside groups in for data.
The way it’s written now is so wrong in so many ways. As you pointed out if it’s 10 bucks who cares - and even at your 100$ I’m very unimpressed - as that’s the “goal” - they operate 8 hours a day 5 days a week - they aren’t open weekends. So let’s call it 260 working days a year. Using the 100$ model the “goal” is $520,000 annual revenue. Which is pathetic. At the $300 I pulled from the Oregon experience - $1,560,000 annual revs are the “goal” which is another grotesquely low number. As an “end goal” for testing the cannabis for an entire country of 38 million people.
Looking at it from a shareholders perspective the absolute highest price would be the best. When the PR says 20 is their goal - and they spent 1.1 million on equipment upgrades less than 60 days ago. I’d like to hope the price to “test a sample” is pushing $900-$1200 or more
That would see a “goal” of $4,680,000 - $6,240,000 in Canada testing revenues (goal = 20 tests a day)
We are left to wonder. The problem lays in the interpretation of this oversight of data or intel in the PR - a cynical person could say that the number is low. And the company wants to avoid dealing with the fallout so they don’t put out a number. Or. The cynic might say that whoever put together the PR completely blanked on realizing that putting $ context into the PR was key to it reading well. And without it it kinda looks like a nothing burger.
They could have included the dollar number. They could have walked us through a quick block of the processs. Provided context to how many tests today. What are those challenges exactly to reaching your goal of 20. Or 40. Engage us.
The way it’s written now provides no context - it’s just another puff piece in a way when you drill down.
Raises more questions than it answers - which is an insta-fail in a corporate press release.
EVIO Canada’s Keystone Labs Prospers in Ever Growing Cannabis Legalization
BEND, Ore.--(BUSINESS WIRE)--EVIO Inc. (“EVIO” or the “Company”), (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, announced that EVIO Canada’s Keystone Labs in Edmonton is ready to prosper and service the Canadian cannabis legalization market. According to cannabis research firm ArcView, legal cannabis sales across North America have increased by 33% in 2017 and forecast to grow by an average of 28% per year through 2021, leading to nearly $25 billion in annual sales. Since legalization in Canada on October 17, 2018 many legal retail outlets across Canada have reported selling out of stock and Licensed Producers are struggling to replenish supplies.
“We anticipate testing 20 cannabis samples per day following Health Canada’s requirements by spring 2019. The goal will be to test 40 samples per day by the end of 2019. Keystone Labs plans to duplicate equipment and add additional technical staff to meet ongoing growth”
Tweet this
Canada is showing strong sales, as reported by Deloitte’s market report, stating the Canadian market will be worth at least USD 5 Billion per year in sales to start.
On the heels of the recent announcement of Keystone Labs investing in significant expansion of the lab and equipment upgrades, this will increase testing volumes, resulting in enhanced operating productivity and revenue growth. “We anticipate testing 20 cannabis samples per day following Health Canada’s requirements by spring 2019. The goal will be to test 40 samples per day by the end of 2019. Keystone Labs plans to duplicate equipment and add additional technical staff to meet ongoing growth,” stated Jodi McDonald of EVIO Canada’s Keystone Labs.
Health Canada has recently increased the requirements for stringent pesticides testing. On January 2, 2019, licensed producers and processors will be required to use third party analysis to confirm the absence of 96 pesticides in all cannabis products. Keystone Labs will meet the Canadian industry demand with new specialized equipment. https://www.businesswire.com/news/home/20181107005222/en/EVIO-Canada’s-Keystone-Labs-Prospers-Growing-Cannabis
Recreational marijuana is now legal in Michigan
after voters passed Proposal 1https://www.wxyz.com/news/political/proposal-1-passes-in-michigan-legalizing-recreational-marijuana-abc-projects
Ego Is the Enemy of Good Leadership
the higher leaders rise in the ranks, the more they are at risk of getting an inflated ego. And the bigger their ego grows, the more they are at risk of ending up in an insulated bubble, losing touch with their colleagues, the culture, and ultimately their clients. Let’s analyze this dynamic step by step.
As we rise in the ranks, we acquire more power. And with that, people are more likely to want to please us by listening more attentively, agreeing more, and laughing at our jokes. All of these tickle the ego. And when the ego is tickled, it grows. David Owen, the former British Foreign Secretary and a neurologist, and Jonathan Davidson, a professor of psychiatry and behavioral sciences at Duke University, call this the “hubris syndrome,” which they define as a “disorder of the possession of power, particularly power which has been associated with overwhelming success, held for a period of years.”
An unchecked ego can warp our perspective or twist our values. In the words of Jennifer Woo, CEO and chair of The Lane Crawford Joyce Group, Asia’s largest luxury retailer, “Managing our ego’s craving for fortune, fame, and influence is the prime responsibility of any leader.” When we’re caught in the grip of the ego’s craving for more power, we lose control. Ego makes us susceptible to manipulation; it narrows our field of vision; and it corrupts our behavior, often causing us to act against our values.
Our ego is like a target we carry with us. And like any target, the bigger it is, the more vulnerable it is to being hit. In this way, an inflated ego makes it easier for others to take advantage of us. Because our ego craves positive attention, it can make us susceptible to manipulation. It makes us predictable. When people know this, they can play to our ego. When we’re a victim of our own need to be seen as great, we end up being led into making decisions that may be detrimental to ourselves, our people, and our organization.
https://hbr.org/2018/11/ego-is-the-enemy-of-good-leadership?utm_campaign=hbr&utm_medium=social&utm_source=linkedin
PDX is referencing the Portland acquisition. The point being what market signals led management to make such a large purchase. In a small, limited, over saturated market. That we see from the financials saw significant demand for services evidenced by dropping revenues. This team saw fit to spend a fortune on an acquisition. Meanwhile the media messaging budget is suffering greatly as evidenced by the low volume and lack of buzz around the Canada launch. The worlds first bio marker. There’s no narrative being sold for people to believe in. We’ve seen the communications just dry up. Is managements mispreading of the Oregon market and expenditure representative of their overall positioning. Silo thinking. We know everything. Why spend money on marketing the companies overall message of securing the safety of the Worlds fastest growing industry seem to think that investors organically will just figure it out. Three years and counting. RTher than budget for investor relations they see fit to spend money and dilution on an acquisition that delivered a massive drop in revenues. There seems to be a need for voices outside of the echo chamber/ silo in the boardroom
PDX acquisition is looking very pricey in light of OR limited cash flow capacity? Not sure of the decision making there. How can you be so intimately involved in a marketplace and not see the obvious future. Silo management think can get you to decisions like that. Everyone sniffing your butt and soon your convinced that your farts DO smell like roses.
Best Ways To Play The U.S. Cannabis Industry (Part 1)
Nov. 2, 2018 12:40 PM
Summary
The U.S. cannabis market is poised for strong growth and more companies are seeking to list in Canada.
We will discuss stocks that operate in the U.S. cannabis market including licensed operators and 'Pick and Shovel' plays.
The U.S. cannabis market is growing fast and will continue to be shaped by increasing M&A activities and attainable organic growth.
Earlier this year we started telling our readers that the U.S. cannabis sector will become an important cannabis market in the months and years to come and investors should take a serious look
expect the current landscape to continue changing driven by M&A activities. In Part II of the series, we will try to synthesize all the information presented here and propose a framework for deciding which stocks are worth owning in order to capitalize on the U.S. cannabis market.
https://seekingalpha.com/article/4217607-best-ways-play-u-s-cannabis-industry-part-1
global stock markets have labored against a number of notable headwinds, notably the Federal Reserve’s tightening of monetary policy, via both interest-rate increases and contraction of the central bank’s balance sheet, plus escalating trade tensions between the U.S. and China. But from the standpoint of the calendar, U.S. equities are entering what historically has been their most profitable period.
It should come as no surprise that politics plays a big part of it. The midterms will be blessedly over after Tuesday, and history says that stocks do better in the aftermath of these elections.
https://apple.news/Aztr1HPs5Tw6GRhMr91LHWA
Capital cost savings are likely a wash - real estate/ logistical/staffing/permitting savings are a wash w extra equipment costs from an expenditure standpoint.
Shareholders like the increased costs that will keep out competitors/ EVIO test work flow experience will be a big help in getting to cash flow positive status in play faster than competitors and the revenues will reflect this.
2019 California should deliver $10,000,000 and could deliver $20,000,000 in revenues. 2019 Canada $5-10 Million. Remains to be seen if they are prepared to do what it takes to reach those attainable revenue goals.
Prep EVIO German crosslisting - Buy buy buy
https://www.finanztrends.info/news/lp/lp569-aktien-chart-analyse/?adref=1814-0&wkz=Evio&isin=US30051V1061
Pick & Shovel market position delivers guaranteed cash flow - Josiah Belden became the mayor of San Jose and owned a couple of blocks in downtown San Francisco with pick and shovel cash flow back in the day https://cdnc.ucr.edu/cgi-bin/cdnc?a=d&d=SFC18920424.2.75&e=-------en--20--1--txt-txIN--------1
1000 good 10,000 great 50,000 = $7,450,000 revenues @ $150 per box - big ??
https://key-box.ca
1-844-319-8133
-in both $evio Instagram and keystone accounts promo evernta for this product in Canada coinciding with launch of legal cannabis in Canada! LP revenues are assured and now the lucrative home grow/ medical/ compassionate care community across the country can determine exactly what they’re dealing with for an affordable cost. Which is awesome if you’re in the middle of nowhere. Which is; let’s be honest. lots of Canada.
They need to continue to improve their communication apparatus to share their narrative in a more consistent and transparent fashion because as much as what you outline is true. The fact is they are trading this morning below book value. Some how the message is continuing to get lost, in fact it never gets told in any way that anyone outside a very small echo chamber EVER hears. Why for example wasnt the fact that Health Canada announced last friday mandatory testing for Jan 2, 2019 its own PR? You had the SEDAR thing about withdrawing the prospectus. Crickets from the messaging team when an opportunity existed to spin the shit out of a revenue quintupling announcement, on a day when speculation is flying wildly about even the future solvency of the company being at stake as the lack of any clarification was left to the imaginations of fact starved shareholders and the evil machinations of short sellers, market makers and other astroturfing trolls bashing the deal and management. Too many missed opportunities i guess is the recipe for trading below book value on the day of the launch of Candadas 10 Billion dollar Cannabis marketplace
“Mandatory Cannabis Testing for Pesticide Active Ingredients” will be in effect on January 2, 2019.
The laboratory expanded its footprint from 3,000 to 6,000 square feet to be able to put in new instruments needed for the required regulated pesticides testing for adult cannabis required by Health Canada.
The laboratory has also purchased state-of-the-art equipment including the GC-MS with CTC for Terpene Residual Solvent Testing and ICP-MS for Heavy Metal Testing. These machines will be instrumental to the requirements required for adult cannabis compliance testing.
All cannabis produced and sold by Licensed Producers will be required to test for the absence of the 95 listed pesticides, the testing must be performed at a third-party laboratory.
The laboratory has purchased LC-MS Triple Quad and GC-MS Triple Quad in preparation for the mandatory pesticide testing.
$EVIO Canada’s Keystone Labs in Edmonton invested $1,100,000 in facility expansion and new equipment upgrades to prepare for adult cannabis legalization with the required regulated and compliance testing.
Canada makes history today with Canada's Parliament bill C-45, known as the Cannabis Act. Parliament bill C-45 has paved a path for Canada to become the first industrialized country in the world to have legalized recreational marijuana.
The legal pot market is projected to expand at a compound annual growth rate of 19.75% over the next 13 years, making it one of the fastest growing areas of the global economy by a wide margin.
The laboratory expanded its footprint from 3,000 to 6,000 square feet to be able to put in new instruments needed for the required regulated pesticides testing for adult cannabis required by Health Canada.
The laboratory has also purchased state-of-the-art equipment including the GC-MS with CTC for Terpene Residual Solvent Testing and ICP-MS for Heavy Metal Testing. These machines will be instrumental to the requirements required for adult cannabis compliance testing.
Et tu Brutus? Kenevir Research is $EVIO Medford -- Check with EVIO media relations Cheryl Kramp info@EVIOlabs.com
"DEA-approved partner, which we haven't announced yet, can actually begin to do medical research, clinical trials if necessary, [and] create the data set that enables people to know when, what, where, and maybe it can become federally regulated in the U.S. with some input that way," Linton said in an interview on "Mad Money."
Cannabis could disrupt a $500 billion market, says CEO of top marijuana maker after deal with DEA
Canopy's news comes less than one month after competing Canadian marijuana producer Tilray announced DEA approval to import cannabis to the United States for medical research at the University of California San Diego Center for Medicinal Cannabis Research.
California is one of eight states, excluding the District of Columbia, to fully legalize medical and recreational marijuana use. Thirty U.S. states currently have laws legalizing medical marijuana use in some form.
Today, the world has its eyes on Canada, where full legalization of adult marijuana use is set to take effect on Oct. 17.
While the windfall will likely be massive for producers like Canopy, Linton is focused on the longer-term global opportunity.
The CEO said Thursday that cannabis could disrupt some $500 billion worth of global markets, calling that a more "accurate" estimate than "conservative, cautious" predictions of a $200 billion disruption.
The issuer should also set out in the letter the reasons why it wishes to withdraw the preliminary prospectus.
Upon receipt of the withdrawal letter from the issuer, staff of the principal regulator will post a public notice on SEDAR confirming that the preliminary prospectus has been withdrawn.
http://www.osc.gov.on.ca/en/prospectus-filing.htm#ten
$EVIO trading below book value. One direction now?
So what is your actual point in this board? I have been here for over three years following the company closely. You have been here for at least half that time. And your only role appears to be to show up around the time news or new events are breaking and to shit all over the deal. Just to come here and crap all over any momentum that appears with parachuted in tactical smears. Why do you keep coming back in to just consistently shit all over the deal? Your attitude towards the stock is evident as you continue to stop in and savor all over the deal so how could you own any stock? I mean all you do is shit all over the deal. And yet time and time and time again you keep coming back to the board to constantly remind everyone who will losten that it’s a shit deal.
Why? Oh why oh why? You could not own any paper in such a terrible deal that you keep coming back to to remind everyone in your smug condescending 3rd person voice of just how terrible the deal is. Yet you keep coming back. Like you had an axe to grind or maybe an agenda outside of not being a shareholder?
Like you almost were paid to shit all over the stock? Because what kind of idiot asshole would just keep coming back to a board every few weeks for months and months and months and have nothing positive to add to a board and only showed up to slander all over a deal whenever any hint of positive momentum appears. There’s the Tarballs to throw shade - real coincidence don’t you think.
Objective Fact Snapshot 15 Canada Cannabis Stock Volume leaders on Canadian markets (Canadian Stock Exchange, TSX Venture) as of 11:17AM EST 10/1/18 -
The market was open for 1 hour and 47 minutes and of the 15 largest volume Cannabis connected stocks over 38,000,000 38 million shares traded hands in that time frame.`With a value of over $1.1 BILLION dollars. In 107 minutes.
Like $EVIO these 15 stocks are all cash flowing legit deals. Contrast that atmosphere to the OTCQB where $EVIO currently trades and im not going to do the actual breakdown like for Canada, but as users of this board will likely be aware of, the majority of the Cannabis deals on the OTC and trading in the US are Hot Garbage, Shells, promos, multi share dilutiuons into the billions, huge volumes trades going for 1/100ths of a cent. Not a place where anyone with a mortgage and an eye to the future is going to being laying out large investment coin, typically.
Thats the place $EVIO has been quarantined for 3 years now. Living with Hot Garbage all around them everyday.
$EVIO is in a time frame today, from submission of their prospectus to the Canadian SEC, of now being in a window where going live and trading on this voracious market into these Canadian traders who have access to every other type of deal in Cannabis EXCEPT a lab play - are going to be RAVENOUS for the EVIO Labs narrative in their portfolio.
This is my best guess as to whats happening now with volume trending up and big bids flashing up every couple of hours for the past couple of weeks.
The prelim prospectus is likely looking good in Canada. Likely the whispers are the preliminary is good and everyone knows the "final prospectus" is just rubber stamping. Anything "ugly" happens during the preliminary process. Those whispers are getting out and people are loading up as much as they can buy quietly on the OTC.
Canada stock traders over the past 10 years have been shifting their portfolios for the most part into TFSA accounts. Their IRA/ROTH equivalent. The problem for $EVIO has been that OTC traded stocks are NOT eligible to be traded in TFSA accounts if the equity ($EVIO) is not crosslisted/trading on a recognized Canadian exchange. OR a recognized international equivalent Frankfurt, Hong Kong...etc
Canadians CAN trade in $EVIO now, buying from the OTC in US$, no problem. But as a percentage of the overall retail market, this group is VERY tiny. Mostly legacy traders from the pre-TFSA accounts, some day traders and mostly that subset of lunatics who love them some penny stocks, yee hah! Also the many many many outright frauds - especially in the 2000-2010 era actually pushed many of the Popular! Canadian trading platforms to just ban any trading of an otc/pink deal that isnt cross listed somewhere that has regulatory/ reporting structure aligned more with the Canadian laws than the wild west of the OTC.
the Thinking being, yeah YOUR specific deal may be just fine, but the other ten are just hot garbage and the fallout of angry everybody, due diligence, SEC involvement at some point, fraud etc was just too likely so why bother at all, kind of thinking.
Summary: Canadian stock investors interested in having a lab play in their portfolio will now have that opportunity. The "regulations" narrative will appeal strongly to the narrow Canaidan mindset of government knows best. The deals alongside will be Tilray, Canopy, Aurora Aphria and not Uncle Jizzmasters latest jerk off stock dump w some rando F- list celebrity attached dumping 12,000,000 shares a session.
(if only the EVIO management team could get their collective media act together to leverage this potential more it wouldnt leave rando casual observers like me to make these very obvious points to inform shareholders - the investor relations team they dont have on staff currently, could be doing the work for them instead?)
Prospectus for Canada listing was submitted June 28
36,000 on the bid @ 0.88
Prospectus for Canada listing was submitted June 28 - "typically" a crosslist as structured, cash flowing, treasury funded, solid team, directors should see 120-180 days to approval to list/trade - although the sector isnt typical and the management isnt typical
https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00045196
90 days now - could be the preliminary prospectus looks positive? and the final prospectus and the list/ trade in Canada will be on like Donkey Kong.
$EVIO 9/27 close is $1.17CAD - the probability of that number blowing up along with volume of 300+500 as the new daily once the snow settles in the north is trending.
wild ass guesstimation is $evio are trading live in canada 10/22 - 11/22
Never attribute to malice that which is adequately explained by stupidity
When is $EVIO going LIVE in Canada to trade on the Canadian Stock Exchange? (CSE) - supplementary... Any thoughts on what the access to trading EVIO in Canada will do with the volume and the price?
No, you are the one being exposed as ridiculous. We are pointing out the obvious problems/ conflicts of interests/ blatant mismanagement directly affecting shareholders and shareholder value - and youre making excuses for management as though the 200% share price drop/ super dilution of structure of the past 9 months never happened. We were promised salvation from all of this nonsense in 2018 - Well here we are and management and its proxies are still making excuses and still havent delivered anything - expect excuses. Y'alll can play ostrich but the total lack of volume and price collapse means youre playing to a smaller and smaller crowd.